Publication | Open Access

Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab

Cancer ImmunosurveillanceGenitourinary CancerMedicineImmunologyPathologyImmune Checkpoint InhibitorOncologyRadiation OncologyLung Cancer